Determining cost-saving risk thresholds for statin use

A threshold for statin prescription in Germany set at a 10.2% 10-year CV risk could significantly increase the number of patients benefiting from statin therapy, reducing CV events and generating substantial cost savings. These findings suggest that adjustments to prescription guidelines could improve cardiovascular outcomes and economic efficiency within the German healthcare system.

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2025-03-13
DOI
https://doi.org/10.1371/journal.pone.0318454
Citations
1
Primary Topic
Health Systems, Economic Evaluations, Quality of Life
Type
article
Field-Weighted Citation Impact
3.13
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Determining cost-saving risk thresholds for statin use

Afschin Gandjour
1 citations
PLoS ONE
Health Systems, Economic Evaluations, Quality of Life
3.13
article

Determining cost-saving risk thresholds for statin use

Afschin Gandjour
article en
1 citations

Abstract

A threshold for statin prescription in Germany set at a 10.2% 10-year CV risk could significantly increase the number of patients benefiting from statin therapy, reducing CV events and generating substantial cost savings. These findings suggest that adjustments to prescription guidelines could improve cardiovascular outcomes and economic efficiency within the German healthcare system.

PLoS ONEVol. 20(3)
Frankfurt School of Finance & Management (DE)
Openalex Percentile: Top 9%
Health Systems, Economic Evaluations, Quality of Life
3.13
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Determining cost-saving risk thresholds for statin use — Afschin Gandjour · PLoS ONE (2025) | TGRS Research Map | TGRS